The Washington Post
By John Solomon
June 14, 2007

An internal FBI audit has found that the bureau potentially violated the law or agency rules more than 1,000 times while collecting data about domestic phone calls, e-mails and financial transactions in recent years, far more than was documented in a Justice Department report in March that ignited bipartisan congressional criticism.

The new audit covers just 10 percent of the bureau's national security investigations since 2002, and so the mistakes in the FBI's domestic surveillance efforts probably number several thousand, bureau officials said in interviews. The earlier report found 22 violations in a much smaller sampling.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

F.D.A. Panel Rejects Drug for Obesity

| | Comments (0)

The New York Times
June 14, 2007
By STEPHANIE SAUL

A drug once viewed as a possible magic bullet against obesity was rejected yesterday by a federal advisory panel because of worries that it causes neurological and psychiatric problems and increases the risk of suicide.

Although the drug, rimonabant, is already marketed in 37 countries, it is now unlikely that the Food and Drug Administration will approve its sale in the United States without additional safety data.

The advisory panel voted unanimously, 14 to 0, against recommending the drug, saying there was inadequate evidence of its safety. The F.D.A. is not required to follow the advice of such panels, but it typically does.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

NewScientist.com news service
13 June 2007

When a well-respected doctor raises concerns about the side effects of an important medicine, you'd expect drug safety officials to investigate. Instead, a spokesman for the US Food and Drug Administration is alleged to have chosen a different strategy: smearing the doctor in question.

Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic in Ohio, investigated the safety of the diabetes drug Avandia, in a study published in The New England Journal of Medicine this March. Avandia is approved by the FDA, but Nissen found that it significantly increased the risk of heart attack. It was the latest blow to the FDA, which has been repeatedly criticised for failing to spot dangerous side effects.

According to ABC News, FDA spokesman Douglas Arbesfeld emailed health reporters drawing attention to a blog that accuses Nissen of focusing his criticism on drug manufacturers that do not run trials at the Cleveland Clinic - a charge Nissen rejects. The FDA declined to comment.

From issue 2607 of New Scientist magazine, 13 June 2007, page 7

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

CBS News
June 12, 2007

(CBS/AP) Regulators on Monday said Sanofi-Aventis' obesity treatment Acomplia may trigger suicidal behavior and other psychological side effects in some patients.

The Food and Drug Administration posted online its review of the drug — deemed effective for losing weight — ahead of a Wednesday meeting at which outside experts will vote on whether it should be approved. The agency does not have to follow the experts' vote, though it often does.

“It works by blocking the receptors in your brain that make you hungry,” reports CBS News medical correspondent Dr. Jon LaPook. “There are other medicines out there; there’s Meridia, there’s Orlistat, but this is a whole new type of medicine that can work in a different way.”

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

U.S. News and World Report
By Deborah Kotz
June 8, 2007

A single nutrient that keeps bones strong, wards off cancer, and protects against tuberculosis, diabetes, colds, and the flu. Sound too good to be true? There's more: It's free. But you're almost certainly not getting enough.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

CNN.com
June 12, 2007

Story Highlights

• 75,000 Marines, families exposed to toxic tap water, health official said
• Chemicals in water may be carcinogens
• Children on based have had cancer and other disorders
• 850 former Camp Lejeune residents have filed legal claims

WASHINGTON (CNN) -- Some 75,000 Marines and their families at Camp Lejeune in North Carolina were exposed to toxic tap water that may have caused cancer and birth defects, a federal health official testified Tuesday.

Results of a new study of the base's water were released Tuesday, the same day lawmakers heard emotional testimony from families who were affected by the water, which contained 40 times the amount of toxins considered safe by today's standards.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

www.rense.com
Jeff Rense
June 12, 2007

Note - This is likely the biggest non-surprise 'study result' of the last 50 years. The vile, despicable commercial food industry has been POISONING hundreds of millions of children and destroying the lives of many of them for decades...with total, leering impunity. There has never been any question that these chemicals and 'additives' approved as 'safe' by the hideously corrupt Monsanto/Big Pharma/Factory Farming/AMA-dominated FDA - and the FSA in the UK - are toxic, life-altering, life-destroying POISONS.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Potentially Incompatible Goals at F.D.A.

| | Comments (0)

The New York Times
June 11, 2007
News Analysis
By GARDINER HARRIS

Safety and speed are the yin and yang of drug regulation. Patients want immediate access to breakthrough medicines but also want to believe the drugs are safe.

These goals can be incompatible. Race a drug to market and much is likely to remain unknown when patients take it. Test a drug thoroughly to assess all possible risks and its release may be delayed by years.

A series of drug-safety scandals has led many on Capitol Hill to question whether the Food and Drug Administration has failed to strike the right balance between speed and safety. A clear sign of this imbalance, these critics say, is the increasing number of F.D.A. drug-safety officers who say they have been punished or ignored after uncovering dangers of popular medicines.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

NewsTarget.com
June 8 2007
by Mike Adams

The Food and Drug Administration has been gleefully warning us about the dangers of China-made food and personal care products recently. Why gleefully? Because announcing the discovery of toxic chemicals in products made by other countries (especially a Communist country) allows the FDA to appear as if it's protecting the public without having to tell the truth about the toxic chemicals found in American food and personal care products. Talking about the deadly chemicals and poisons used by American food and personal care product manufacturers is, of course, an activity to be avoided at all costs. It's much easier to point the finger of blame at someone else and imply that U.S. manufacturers of such products would never poison their customers.

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (1 votes cast)

NewsWithViews.com
June 7, 2007
By Byron J. Richards, CCN

The Andrew von Eschenbach FDA era is upon is. The Avandia scandal is the tip of the iceberg. Is anyone ready? The words "illicit financial collusion" have been replaced by the politically correct term, "collaboration." On May 30, in defense of his cozy relationship with Big Pharma and Big Biotech von Eschenbach told reporters, "This is a collaboration, but it's not just a collaboration with drug companies, it's a collaboration with academia and with other agencies." And he forgot to include that it is also a collaboration with various Senators, such as Senator Bennett (R-UT) and Senator Hatch (R-UT), as can be seen by the highly lucrative Critical Path Initiative program for cardiovascular disease research at the University of Utah.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Recent Comments

Other sites of ours